Zenith Health

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812B01026
  • NSEID:
  • BSEID: 530665
INR
3.22
-0.06 (-1.83%)
BSENSE

Apr 20

BSE+NSE Vol: 20.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 10.71% vs -6.67% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 11.33% vs 5.04% in Mar 2024

Compare Balance Sheet Results of Zenith Health
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.37
1.50
3.87
258.00%
Share Warrants & Outstandings
Total Reserve
2.03
11.64
-9.61
-82.56%
Shareholder's Funds
7.41
13.14
-5.73
-43.61%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.02
-0.01
0.03
300.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.02
-0.01
0.03
300.00%
Current Liabilities
Trade Payables
1.36
0.00
1.36
0.00%
Other Current Liabilities
2.03
0.01
2.02
20,200.00%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.06
0.20
-0.14
-70.00%
Total Current Liabilities
3.45
0.21
3.24
1,542.86%
Total Liabilities
10.88
13.34
-2.46
-18.44%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
7.45
0.11
7.34
6,672.73%
Less: Accumulated Depreciation
5.89
0.10
5.79
5,790.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.55
0.01
1.54
15,400.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.01
-0.01
-100.00%
Long Term Loans & Advances
0.97
2.51
-1.54
-61.35%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.53
2.53
0.00
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
2.27
0.00
2.27
0.00%
Sundry Debtors
2.42
0.00
2.42
0.00%
Cash and Bank
2.74
10.62
-7.88
-74.20%
Other Current Assets
0.27
0.19
0.08
42.11%
Short Term Loans and Advances
0.65
0.00
0.65
0.00%
Total Current Assets
8.35
10.81
-2.46
-22.76%
Net Current Assets (Including Current Investments)
4.90
10.61
-5.71
-53.82%
Total Current Assets Excluding Current Investments
8.35
10.81
-2.46
-22.76%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
10.88
13.34
-2.46
-18.44%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
1.38
87.63
-86.25
-98.43%
Annual - Borrowings
Markets Mojo
No Borrowings in the last few periods
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 1.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 10.71% vs -6.67% in Mar 2024

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 8.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.33% vs 5.04% in Mar 2024